Home / World News / US FDA ends emergency use of hydroxychloroquine to treat Covid-19

US FDA ends emergency use of hydroxychloroquine to treat Covid-19

The decision on the so-called 'wonder drug' as touted by the US President Donald Trump is taken in the wake of recent clinical trials

Premium

US President Donald Trump at The White House. AP

IANS Washington

2 min read Last Updated : Jun 16 2020 | 7:38 AM IST

The Food and Drug Administration (FDA) on Monday announced to withdraw the emergency use authorisation (EUA) for chloroquine and hydroxychloroquine (HCQ) as treatment for severe COVID-19 patients.

The decision on the so-called 'wonder drug' as touted by the US President Donald Trump is taken in the wake of recent clinical trials that showed that the antimalarial drugs were not effective against the coronavirus.

"In light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits" of hydroxychloroquine no longer outweigh those risks, the FDA wrote on its website on Monday.

On March 28, the US FDA issued

Topics : Coronavirus Lockdown Donald Trump US FDA US Food and Drug Administration

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in